Clifford M Takemoto (Clifford Takemoto, Cliff Takemoto)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Sickle Cell Disease

Acute Lymphoblastic Leukemia

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Patricia Barker, Delia Charest Carias, Timothy Jacobs, Philip Carpiniello, Clifford M Takemoto, Jay Lieberman, Elisabeth Adderson
Promoting penicillin allergy de-labeling for children attending a hematology clinic. Pediatric blood & cancer (2024)
Jennifer N Longoria, Christina M Dandar, Joshua H Semko, Janaka S S Liyanage, Guolian Kang, Halle T McCracken, Erin MacArthur, Catherine R Hoyt, Jane Silva Hankins, Clifford M Takemoto, Andrew M Heitzer
Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease. Pediatric blood & cancer (2024)
Jennifer N Longoria, Christina M Dandar, Joshua H Semko, Janaka S S Liyanage, Guolian Kang, Halle T McCracken, Erin MacArthur, Catherine R Hoyt, Jane Silva Hankins, Clifford M Takemoto, Andrew M Heitzer
Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease. Pediatric blood & cancer 71 (10) (2024)
Nathan Gray, Kacie Sims, Sara Lewis, Shaohua Lei, Nidhi Bhatt, Gabriela Gheorghe, Clifford M Takemoto, Marcin W Wlodarski
The ghost of parvovirus past: Idiopathic pure red cell aplasia responding to IVIG following resolved perinatal parvovirus B19 infection. Pediatric blood & cancer (2024)
Patricia Barker, Delia Charest Carias, Timothy Jacobs, Philip Carpiniello, Clifford M Takemoto, Jay Lieberman, Elisabeth Adderson
Promoting penicillin allergy de-labeling for children attending a hematology clinic. Pediatric blood & cancer 71 (7) (2024)
Clifford M Takemoto
Pediatric stroke and thrombophilia-To test or not to test? Pediatric blood & cancer (2023)
Kristen M Snyder, Clifford M Takemoto
Introduction: The changing role of the pediatric hematologist/oncologist in the care of people with vascular anomalies. Pediatric blood & cancer (2022)
Richa Sharma, Clifford M Takemoto, Benjamin Waller, Ashley Holland, Ching-Hong Pui, Hiroto Inaba
Reduced intensity chemotherapy with tyrosine kinase inhibitor and blinatumomab in a pediatric patient with Philadelphia chromosome-positive ALL and mechanical heart valves. Pediatric blood & cancer 68 (6) (2021)
Yixin Hu, Kenneth J Caldwell, Mihaela Onciu, Sara M Federico, Marta Salek, Sara Lewis, Shaohua Lei, Jinghui Zhang, Kim E Nichols, Clifford M Takemoto, Brandon M Triplett, Jason E Farrar, Jeffrey E Rubnitz, Raul C Ribeiro, Marcin W Wlodarski
CPX-351 Induces Remission in Newly Diagnosed Pediatric Secondary Myeloid Malignancies. Blood advances (2021)
Janet Crane, Jackie Manfredo, Elisa Boscolo, Mara Coyan, Clifford M Takemoto, Maxim Itkin, Denise M Adams, Timothy D Le Cras
Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels. Pediatric blood & cancer 67 (9) (2020)
Isha Darbari, Emily Jacobs, Olivia Gordon, Diane Weiss, Kim Winship, James F Casella, John J Strouse, Clifford M Takemoto
Correlates of successful transition in young adults with sickle cell disease. Pediatric blood & cancer 66 (12) (2019)